Biomedical

Winthrop-University Hospital opened the $110 million Research and Academic Center in February of 2015 in Mineola, N.Y. Designed by Perkins Eastman, the five-story, 95,000-sf facility will support translational research on pediatric and adult diabetes in conjunction with patient care and community education. The center provides classrooms, a clinical trials center, a simulation training suite, a 350-seat auditorium, and core labs for the study of diabetes, obesity, cardiopulmonary disease, and neurology.

Michigan State University is planning to build an $85 million research facility for the College of Human Medicine in Grand Rapids. The 163,000-sf facility will feature opens labs for team-based research and is slated for completion in fall of 2017. SmithGroupJJR is providing architectural and engineering services for the project, and the facility will be built by a joint venture of Rockford Construction and Clark Construction Company.

McGill University Health Centre opened its new $310 million Research Institute in Montreal in February of 2015. Designed to support the integration of research and clinical care, the facility houses the Centre for Translational Biology, the Centre for Outcomes Research and Evaluation, and the McConnell Centre for Innovative Medicine, which will accommodate clinical trials. The design and construction cost of the Research Institute was $210 million with $100 million for equipment and instrumentation.

The four-story, 80,000-sf Research and Graduate Education Complex on the campus of Northeast Ohio Medical University (NEOMED) is a state-of-the-art biomedical research facility for researchers from the colleges of Pharmacy, Medicine, and Graduate Studies. Three floors of laboratories and support spaces house more than 30 scientists and their teams, with space for 156 bench researchers. The building also contains office space for faculty, write-up areas for research staff and students, and small-group teaching and seminar rooms.

The Wuhan Institute of Virology completed construction in January of 2015 on China's first maximum containment biosafety laboratory. Located in the Hubei province, the facility will support research on Class 4 Pathogens (P4) including Ebola and smallpox. The lab was created in partnership with the Chinese Academy of Sciences and Institut Merieux, a French biomedical firm. Construction began on the project in July of 2011.

The National University of Ireland Galway began construction in January of 2015 on the 88,000-sf Human Biology Building. Designed by Scott Talon Walker Architects, the five-story teaching and research facility will provide labs, lecture halls, and offices for the departments of anatomy, physiology, and pharmacology. The Human Biology Building will also include a vivarium, a microscopy suite, and anatomy and mortuary space. The construction cost of the project is $34 million and the general contractor is BAM Group Ireland.

The New Hampshire Veterinary Diagnostic Laboratory is building a new 6,500-sf facility in Durham. Located on the campus of the University of New Hampshire, the $2.5 million project will support the detection and diagnosis of infectious diseases. The facility represents a partnership between the UNH College of Life Sciences and Agriculture and the New Hampshire Department of Agriculture, Markets & Food.

Coventry University will begin construction in mid-2015 on a $50 million facility for the Faculty of Health and Life Sciences in the United Kingdom. The five-story multidisciplinary building will provide classrooms, simulation suites for medical training, science labs, and core research space. The 121,200-gsf (75,500-nsf) project will be built by BAM Construction. Completion is expected by fall of 2017.

Illumina is planning a 360,000-sf research campus in Foster City, Calif. Developed by BioMed Realty Trust, the build-to-suit project will include two highly flexible laboratory and office buildings as well as outdoor recreation areas. LEED Gold sustainable design certification will be sought for the campus, which is slated for completion in 2017. Illumina, a provider of genomic sequencing and diagnostics solutions, will initially lease the facilities for 15 years.

The seven-story “3.1” research building on the University of Washington Medical School’s South Lake Union campus adds 160,000 nsf of research and research support space for more than 300 occupants to a seven-building master plan totaling 1.2 million gsf.

The three-story International Vaccine Centre (InterVac) at the University of Saskatchewan is one of the largest vaccine research centers in the world and the largest in North America. It is connected by a walkway to the Vaccine and Infectious Disease Organization (VIDO) laboratory building in a cluster of life sciences R&D facilities at the University. The facilities operate together as VIDO-InterVac, one of only a few BSL-3 facilities in the world that can accommodate disease and vaccine research involving animals as large as cows.

The University of Maryland is building a new facility for the Clark School of Engineering in College Park. Ground was broken in November of 2014 on the 184,000-sf A. James Clark Hall, a collaborative, multidisciplinary facility created to support the development of advanced biomedical technologies. Designed by Ballinger, the building will provide a new home for the Fischell Department of Bioengineering and the Robert E. Fischell Institute for Biomedical Devices.

The University of Utah will renovate the existing 71,000-sf George Thomas building to create the Gary & Ann Crocker Science Center in Salt Lake City. The existing structure will be seismically upgraded and reconfigured, and a 52,500-sf addition will be built to accommodate laboratories for the Cell and Genome Research Center. The completed four-story, 123,500-sf facility will also provide lecture halls, classrooms, a café, a business incubator, and a full-height atrium. The project team includes EDA Architects and Okland Construction.

The University of Cambridge has awarded Kier Group a $91 million contract to build a new biomedical laboratory in the United Kingdom. The project will provide up to 180,000 sf of research space and will be located on the Cambridge Biomedical Campus. Site work will begin in mid-2015 with completion expected in summer of 2017.

The Clinical Cell and Vaccine Production Facility (CVPF) at the Hospital of the University of Pennsylvania is designed to facilitate a bench-to-bedside approach, where the clinical materials to treat disease are manufactured and administered within the hospital using cells from the patient’s own body. The project has achieved international recognition for its unique potential for optimizing patient care and for its success treating human immunodeficiency virus (HIV) and cancer.